5th Gene Therapy Immunogenicity Summit 2024 The Westin Boston Seaport District, Boston

The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck ‘here and now’.

The 5th Gene Therapy Immunogenicity Summit is returning to Boston this August, bringing together 100+ immunogenicity experts responsible for predicting, measuring, and mitigating immune response. Join your colleagues as they share their learnings and gain key insights on:

* Effective approaches to promote AAV safety whilst maintaining efficacy
* Preventing the bottlenecks of the potential slowdown of gene therapy development
* Access specific, case-study-led examples across immunogenicity and ask the big-hitting immunology questions to your peers actively working in the space to make clinically safe and effective gene therapies a reality.